Guidelines used from Cochrane Collaboration Group and Grading of Recommendations Assessment, Development and Evaluation (GRADE) system of evaluation
Levels of quality of a body of evidence in the GRADE approach | ||||
Underlying methodology | Quality rating | |||
Randomised trials; or double-upgraded observational studies Downgraded randomised trials; or upgraded observational studies Double-downgraded randomised trials; or observational studies Triple-downgraded randomised trials; or downgraded observational studies; or case series/case reports | High Moderate Low Very low | |||
Factors that may decrease the quality level of a body of evidence | ||||
1. Limitations in the design and implementation of available studies suggesting high likelihood of bias of the intervention effect (randomised allocation sequence, blinding, allocation concealment, intention-to-treat analysis, losses to follow-up) 2. Indirectness of evidence (indirect population, intervention, control, outcomes) 3. Unexplained heterogeneity or inconsistency of results (including problems with subgroup analyses) 4. Imprecision of results (wide CIs) or inconsistency (significant and unexplained variability in results from different trials) 5. High probability of publication bias (‘negative’ findings remain unpublished) | ||||
Factors that may increase the quality level of a body of evidence | ||||
1. Large magnitude of effect 2. All plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect 3. Dose–response gradient (result proportional to the degree of exposure) | ||||
Judgement about study limitations for main outcomes following assessment of risk of bias | ||||
Risk of bias | Across studies | Interpretation | Considerations | GRADE assessment of study limitations |
Low risk of bias | Most information is from studies at low risk of bias | Plausible bias unlikely to seriously alter the results | No apparent limitations | No serious limitations, do not downgrade |
Unclear risk of bias | Most information is from studies at low or unclear risk of bias | Plausible bias that raises some doubt about the results | Potential limitations are unlikely to lower confidence in the estimate of effect | No serious limitations, do not downgrade |
Potential limitations are likely to lower confidence in the estimate of effect | Serious limitations, downgrade one level | |||
High risk of bias | The proportion of information from studies at high risk of bias is sufficient to affect the interpretation of results | Plausible bias that seriously weakens confidence in the results | Crucial limitation for one criterion, or some limitations for multiple criteria, sufficient to lower confidence in the estimate of effect Crucial limitation for one or more criteria sufficient to substantially lower confidence in the estimate of effect | Serious limitations, downgrade one level Very serious limitations, downgrade two levels |
Quality of evidence according to GRADE approach | ||||
Code | Quality of evidence | Definition | ||
A | High ⊕⊕⊕⊕ | Further research is very unlikely to change the confidence in the estimate of effect
| ||
B | Moderate ⊕⊕⊕ | Further research is likely to have an important impact on the confidence in the estimate of effect and may change the estimate
| ||
C | Low ⊕⊕ | Further research is very likely to have an important impact on the confidence in the estimate of effect and is likely to change the estimate
| ||
D | Very low ⊕ | Any estimate of effect is very uncertain
| ||
E | No evidence | No randomised controlled trials were identified that addressed this outcome |
Data in the table were adapted from Cochrane Handbook for Systematic Reviews of Interventions 36